| Literature DB >> 25789765 |
Oishee Bose1, Peter Baluk2, Mark R Looney3, Laurence E Cheng4, Donald M McDonald2, George H Caughey5, Matthew F Krummel6.
Abstract
Mast cells (MC) and myeloid dendritic cells (DC) act proximally in detecting and processing antigens and immune insults. We sought to understand their comparative dynamic behavior with respect to the airway epithelium in the steady state and in response to an allergic stimulus in mouse trachea. We devised methods to label MC in living trachea and to demonstrate that MC and DC occupy distinct layers of the tracheal mucosa, with DC being closer to the lumen. DC numbers doubled after allergen challenge, but MC numbers remained stable. MC and DC migrated minimally in either steady state or allergen-challenge conditions, and their interactions with one another appeared to be stochastic and relatively infrequent. While DC, unlike MC, exhibited probing behaviors involving dendrites, these projections did not cross the epithelium into the airway lumen. MC typically were located too far from the epithelial surface to contact the tracheal lumen. However, MC had protrusions toward and into blood vessels, likely to load with IgE. Thus, DC and MC occupy distinct niches and engage in sessile surveillance in the mouse trachea. Little or no access of these cell types to the airway lumen suggests that trans-epithelial transport of proteins in the steady state would be required for them to access luminal antigens.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25789765 PMCID: PMC4366375 DOI: 10.1371/journal.pone.0118513
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 3Spatiotemporal interactions of anti-OVA IgE Alexa 647 MC and DC in PBS- and OVA-challenged tracheas.
(A) Spatial distribution of anti-OVA IgE Alexa 647 MC and CD11cYFP DC in saline (SAL)-challenged or OVA-challenged trachea. Tracheas were analyzed one day after the third OVA challenge (i.e., on day 24 of the OVA challenge regimen [5]). Side views show distribution in relation to the lumen. Scale bar = 50 μm (see also ) (B). Density of DC and MC was determined by counting each cell type in images and measuring the complete volume of tissue and expressing data as cells/volume. (C) Quantified distribution of anti-OVA IgE Alexa 647 MC and CD11cYFP DC relative to the mucosal edge of tracheas after PBS or OVA challenge. Total cells per region were counted in at least 4 tracheas and expressed as a probability. (D) Mean track speed of anti-OVA IgE Alexa 647-stained mast cells and Cd11cYFP dendritic cells in PBS- and OVA-challenged tracheas. (E) Percent of MCs that had a cell-cell contact when viewed from all angles (see also ).
Fig 4DC- and MC-probing in PBS- and OVA-challenged tracheas.
(A) shows stills from a time lapse movie of a DC from a CD11c-EYFP x Actin-CFP mouse in a PBS-treated trachea and YZ rendering of the same data. Dendritic cell projections are shown moving over time, with a dotted white line marking the cell border at t = 0. See also . (B) contains still images from a second time lapse movie of a dendritic cell from a CD11c-EYFPxActin CFP mouse in an OVA-challenged trachea. Bars: XY = 50 μm; YZ = 10 μm. See also . (C) Protrusions of DC dendrites in 4 tracheas measured to show whether the projection entered the epithelium. (D) Still images from a time-lapse of a MC stained with anti-OVA IgE Alexa 647 (pink) near blood vessels stained by anti-CD31 PE (red). MCs protruding into vessel walls are marked by arrows. (E) Three XYZ-slices are shown, encompassing a thickness of 5 μm and separated from the next by 5 μm, illustrating that the tip of a MC lies near the vessel lumen. The rightmost panel shows a YZ rendering of the same dataset, illustrating the Z-volume rendered in mid-section. (F) The percentage of MC with protrusions that enter the vessel as defined by z-slices was quantified. * P = 0.007.